Skip to main content
Livermore
Livermore
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

OCUL holding history

Ocular Therapeutix, Inc in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OCUL overviewAll 13F holders of OCULFull Q2 2026 holdings

Shares (Q2 2026)
32,844,043
Value
$322.5M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of OCUL by FMR LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202632,844,043$322.5M<0.1%+190,279+0.6%AddedHolders
Q1 202632,653,764$276.6M<0.1%+868,159+2.7%AddedHolders
Q4 202531,785,605$385.9M<0.1%−290.0%ReducedHolders
Q3 202531,785,634$371.6M<0.1%+12,177,463+62.1%AddedHolders
Q2 202519,608,171$182.0M<0.1%+18,666,877+1,983.1%AddedHolders
Q1 2025941,294$6.90M<0.1%+480,847+104.4%AddedHolders
Q4 2024460,447$3.93M<0.1%+26,078+6.0%AddedHolders
Q3 2024434,369$3.78M<0.1%+428,335+7,098.7%AddedHolders
Q2 20246,034$41.3K<0.1%−63,058−91.3%ReducedHolders
Q1 202469,092$628.7K<0.1%−280.0%ReducedHolders
Q4 202369,120$308.3K<0.1%+340+0.5%AddedHolders
Q3 202368,780$216.0K<0.1%+62,793+1,048.8%AddedHolders
Q2 20235,987$30.9K<0.1%+1,236+26.0%AddedHolders
Q1 20234,751$25.0K<0.1%+2,175+84.4%AddedHolders
Q4 20222,576$7.24K<0.1%−2,459−48.8%ReducedHolders
Q3 20225,035$21.0K<0.1%+1,626+47.7%AddedHolders
Q2 20223,409$14.0K<0.1%+1,271+59.4%AddedHolders
Q1 20222,138$11.0K<0.1%+2,138NewHolders
Q4 20210$00.0%−1,135,345−100.0%Sold outHolders
Q3 20211,135,345$11.4M<0.1%−63,592−5.3%ReducedHolders
Q2 20211,198,937$17.0M<0.1%+1,014,069+548.5%AddedHolders
Q1 2021184,868$3.03M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.